Profile | GDS5420 / 205446_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 85.63 | 39 |
GSM1296119 | B_lesional_pre-dose | 121.1 | 43 |
GSM1296076 | C_lesional_pre-dose | 125.78 | 46 |
GSM1296092 | D_lesional_pre-dose | 99.87 | 44 |
GSM1296103 | E_lesional_pre-dose | 51.61 | 32 |
GSM1296078 | F_lesional_pre-dose | 73.14 | 37 |
GSM1296107 | G_lesional_pre-dose | 107.61 | 41 |
GSM1296109 | H_lesional_pre-dose | 78.14 | 36 |
GSM1296080 | I_lesional_pre-dose | 124.97 | 47 |
GSM1296090 | J_lesional_pre-dose | 95.73 | 42 |
GSM1296074 | K_lesional_pre-dose | 107.68 | 45 |
GSM1296111 | L_lesional_pre-dose | 142.35 | 45 |
GSM1296099 | M_lesional_pre-dose | 99.51 | 41 |
GSM1296086 | O_lesional_pre-dose | 91.47 | 41 |
GSM1296117 | P_lesional_pre-dose | 117.17 | 42 |
GSM1296113 | Q_lesional_pre-dose | 165.92 | 47 |
GSM1296096 | R_lesional_pre-dose | 72.13 | 37 |
GSM1296105 | S_lesional_pre-dose | 80.32 | 37 |
GSM1296098 | T_lesional_pre-dose | 102.96 | 41 |
GSM1296101 | U_lesional_pre-dose | 81.62 | 38 |
GSM1296121 | V_lesional_pre-dose | 105.15 | 41 |
GSM1296088 | W_lesional_pre-dose | 153.27 | 49 |
GSM1296082 | X_lesional_pre-dose | 94.6 | 42 |
GSM1296115 | Y_lesional_pre-dose | 143.74 | 46 |
GSM1296084 | Z_lesional_pre-dose | 139.49 | 47 |
GSM1296072 | B_lesional_day8 | 112.16 | 42 |
GSM1296069 | L_lesional_day8 | 135.59 | 44 |
GSM1296071 | P_lesional_day8 | 127.12 | 42 |
GSM1296070 | Y_lesional_day8 | 106.94 | 40 |
GSM1296073 | V_lesional_day8 | 82.67 | 38 |
GSM1296034 | A_lesional_day15 | 91.78 | 39 |
GSM1296041 | G_lesional_day15 | 104.88 | 41 |
GSM1296035 | R_lesional_day15 | 77.14 | 39 |
GSM1296038 | U_lesional_day15 | 79.16 | 38 |
GSM1296047 | B_lesional_day15 | 106.89 | 40 |
GSM1296039 | E_lesional_day15 | 65.64 | 35 |
GSM1296042 | H_lesional_day15 | 129.96 | 43 |
GSM1296043 | L_lesional_day15 | 113.95 | 41 |
GSM1296037 | M_lesional_day15 | 61.1 | 33 |
GSM1296046 | P_lesional_day15 | 106.95 | 40 |
GSM1296044 | Q_lesional_day15 | 111.85 | 40 |
GSM1296045 | Y_lesional_day15 | 143.06 | 44 |
GSM1296025 | C_lesional_day15 | 116.62 | 44 |
GSM1296033 | D_lesional_day15 | 64.32 | 35 |
GSM1296027 | I_lesional_day15 | 95.91 | 43 |
GSM1296032 | J_lesional_day15 | 124.73 | 45 |
GSM1296024 | K_lesional_day15 | 102.16 | 43 |
GSM1296031 | W_lesional_day15 | 117.43 | 43 |
GSM1296028 | X_lesional_day15 | 139.64 | 47 |
GSM1296029 | Z_lesional_day15 | 170.67 | 50 |
GSM1296026 | F_lesional_day15 | 96.1 | 41 |
GSM1296030 | O_lesional_day15 | 114.43 | 46 |
GSM1296040 | S_lesional_day15 | 87.3 | 39 |
GSM1296036 | T_lesional_day15 | 93.96 | 39 |
GSM1296048 | V_lesional_day15 | 100.01 | 40 |
GSM1296059 | A_lesional_day43 | 55.71 | 34 |
GSM1296066 | G_lesional_day43 | 116.21 | 42 |
GSM1296060 | R_lesional_day43 | 66.31 | 35 |
GSM1296063 | U_lesional_day43 | 51.45 | 31 |
GSM1296064 | E_lesional_day43 | 66.54 | 36 |
GSM1296067 | H_lesional_day43 | 139.39 | 44 |
GSM1296062 | M_lesional_day43 | 63.8 | 35 |
GSM1296068 | Q_lesional_day43 | 145.64 | 44 |
GSM1296050 | C_lesional_day43 | 148.31 | 48 |
GSM1296057 | D_lesional_day43 | 82.29 | 39 |
GSM1296052 | I_lesional_day43 | 95.27 | 43 |
GSM1296054 | J_lesional_day43 | 125.7 | 44 |
GSM1296049 | K_lesional_day43 | 151.53 | 48 |
GSM1296055 | W_lesional_day43 | 83.59 | 38 |
GSM1296053 | X_lesional_day43 | 145.3 | 47 |
GSM1296058 | Z_lesional_day43 | 77.42 | 39 |
GSM1296051 | F_lesional_day43 | 79.87 | 39 |
GSM1296056 | O_lesional_day43 | 64.62 | 36 |
GSM1296065 | S_lesional_day43 | 79.13 | 37 |
GSM1296061 | T_lesional_day43 | 81.32 | 38 |
GSM1296095 | A_non-lesional_pre-dose | 66.7 | 36 |
GSM1296120 | B_non-lesional_pre-dose | 96.98 | 39 |
GSM1296077 | C_non-lesional_pre-dose | 128.09 | 46 |
GSM1296093 | D_non-lesional_pre-dose | 114.92 | 43 |
GSM1296104 | E_non-lesional_pre-dose | 31.52 | 23 |
GSM1296079 | F_non-lesional_pre-dose | 90.2 | 40 |
GSM1296108 | G_non-lesional_pre-dose | 78.41 | 36 |
GSM1296110 | H_non-lesional_pre-dose | 95.17 | 37 |
GSM1296081 | I_non-lesional_pre-dose | 70.4 | 38 |
GSM1296091 | J_non-lesional_pre-dose | 117.06 | 45 |
GSM1296075 | K_non-lesional_pre-dose | 81.32 | 39 |
GSM1296112 | L_non-lesional_pre-dose | 122.46 | 41 |
GSM1296100 | M_non-lesional_pre-dose | 60.22 | 33 |
GSM1296087 | O_non-lesional_pre-dose | 68.84 | 38 |
GSM1296118 | P_non-lesional_pre-dose | 111.81 | 40 |
GSM1296114 | Q_non-lesional_pre-dose | 103.98 | 39 |
GSM1296097 | R_non-lesional_pre-dose | 81.03 | 38 |
GSM1296106 | S_non-lesional_pre-dose | 71.79 | 35 |
GSM1296102 | U_non-lesional_pre-dose | 69.29 | 35 |
GSM1296122 | V_non-lesional_pre-dose | 103.25 | 40 |
GSM1296089 | W_non-lesional_pre-dose | 124.4 | 44 |
GSM1296083 | X_non-lesional_pre-dose | 157.27 | 48 |
GSM1296116 | Y_non-lesional_pre-dose | 107.08 | 39 |
GSM1296085 | Z_non-lesional_pre-dose | 102.7 | 42 |